JinkoSolar Holding Co (NYSE:JKS) reported quarterly sales of $2.81 billion which beat the analyst consensus estimate of $2.28 billion by 23.25 percent. This is a 128.83 percent increase over sales of $1.23 billion the same period last year.
Why Novavax Shares Are Plunging Today Despite Much Awaited FDA Emergency Nod?
The European Medicines Agency identified severe allergic reactions as potential side effects of Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine. A few cases of…
